RAMSAY GENERALE DE SANTE SA (GDS.PA) Stock Fundamental Analysis
Europe - EPA:GDS - FR0000044471 - Common Stock
9.96 EUR
0 (0%)
We assign a fundamental rating of 2 out of 10 to GDS. GDS was compared to 27 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of GDS have multiple concerns. GDS has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year GDS has reported negative net income.
In the past year GDS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: GDS reported negative net income in multiple years.
In the past 5 years GDS always reported a positive cash flow from operatings.
1.2 Ratios
GDS's Return On Assets of -0.79% is on the low side compared to the rest of the industry. GDS is outperformed by 85.19% of its industry peers.
GDS's Return On Equity of -4.72% is on the low side compared to the rest of the industry. GDS is outperformed by 85.19% of its industry peers.
The Return On Invested Capital of GDS (2.64%) is worse than 74.07% of its industry peers.
The Average Return On Invested Capital over the past 3 years for GDS is below the industry average of 6.10%.
The last Return On Invested Capital (2.64%) for GDS is above the 3 year average (1.89%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.79% | ||
| ROE | -4.72% | ||
| ROIC | 2.64% |
ROA(3y)-0.29%
ROA(5y)0.37%
ROE(3y)-1.76%
ROE(5y)2.11%
ROIC(3y)1.89%
ROIC(5y)1.48%
1.3 Margins
Looking at the Operating Margin, with a value of 3.57%, GDS is in line with its industry, outperforming 40.74% of the companies in the same industry.
In the last couple of years the Operating Margin of GDS has grown nicely.
GDS's Gross Margin of 77.91% is fine compared to the rest of the industry. GDS outperforms 77.78% of its industry peers.
In the last couple of years the Gross Margin of GDS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.57% | ||
| PM (TTM) | N/A | ||
| GM | 77.91% |
OM growth 3Y29.81%
OM growth 5Y22.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y-0.65%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GDS is destroying value.
GDS has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for GDS remains at a similar level compared to 5 years ago.
GDS has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.01, we must say that GDS is in the distress zone and has some risk of bankruptcy.
GDS's Altman-Z score of 1.01 is on the low side compared to the rest of the industry. GDS is outperformed by 66.67% of its industry peers.
The Debt to FCF ratio of GDS is 7.41, which is on the high side as it means it would take GDS, 7.41 years of fcf income to pay off all of its debts.
GDS has a Debt to FCF ratio of 7.41. This is in the better half of the industry: GDS outperforms 70.37% of its industry peers.
GDS has a Debt/Equity ratio of 3.27. This is a high value indicating a heavy dependency on external financing.
GDS's Debt to Equity ratio of 3.27 is on the low side compared to the rest of the industry. GDS is outperformed by 81.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.27 | ||
| Debt/FCF | 7.41 | ||
| Altman-Z | 1.01 |
ROIC/WACC0.61
WACC4.36%
2.3 Liquidity
A Current Ratio of 0.81 indicates that GDS may have some problems paying its short term obligations.
With a Current ratio value of 0.81, GDS is not doing good in the industry: 70.37% of the companies in the same industry are doing better.
A Quick Ratio of 0.73 indicates that GDS may have some problems paying its short term obligations.
GDS's Quick ratio of 0.73 is on the low side compared to the rest of the industry. GDS is outperformed by 62.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.73 |
3. Growth
3.1 Past
The earnings per share for GDS have decreased by -0.33% in the last year.
The Revenue has been growing slightly by 4.70% in the past year.
The Revenue has been growing slightly by 6.95% on average over the past years.
EPS 1Y (TTM)-0.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.77%
Revenue 1Y (TTM)4.7%
Revenue growth 3Y6.82%
Revenue growth 5Y6.95%
Sales Q2Q%98.83%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for GDS. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GDS is valued a bit cheaper than 70.37% of the companies in the same industry.
96.30% of the companies in the same industry are more expensive than GDS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2 | ||
| EV/EBITDA | 7.69 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for GDS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:GDS (9/12/2025, 7:00:00 PM)
9.96
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners39.92%
Inst Owner ChangeN/A
Ins Owners6.59%
Ins Owner ChangeN/A
Market Cap1.10B
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.21 | ||
| P/FCF | 2 | ||
| P/OCF | 1.58 | ||
| P/B | 0.96 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.69 |
EPS(TTM)-0.49
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.99
FCFY50.11%
OCF(TTM)6.28
OCFY63.09%
SpS47.49
BVpS10.37
TBVpS-10.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.79% | ||
| ROE | -4.72% | ||
| ROCE | 3.59% | ||
| ROIC | 2.64% | ||
| ROICexc | 2.85% | ||
| ROICexgc | 5.42% | ||
| OM | 3.57% | ||
| PM (TTM) | N/A | ||
| GM | 77.91% | ||
| FCFM | 10.51% |
ROA(3y)-0.29%
ROA(5y)0.37%
ROE(3y)-1.76%
ROE(5y)2.11%
ROIC(3y)1.89%
ROIC(5y)1.48%
ROICexc(3y)2.04%
ROICexc(5y)1.59%
ROICexgc(3y)3.83%
ROICexgc(5y)2.97%
ROCE(3y)2.58%
ROCE(5y)2.01%
ROICexcg growth 3Y44.11%
ROICexcg growth 5Y31.78%
ROICexc growth 3Y41.72%
ROICexc growth 5Y29.83%
OM growth 3Y29.81%
OM growth 5Y22.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y-0.65%
F-Score3
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.27 | ||
| Debt/FCF | 7.41 | ||
| Debt/EBITDA | 6.03 | ||
| Cap/Depr | 32.9% | ||
| Cap/Sales | 2.72% | ||
| Interest Coverage | 0.99 | ||
| Cash Conversion | 111.64% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.73 | ||
| Altman-Z | 1.01 |
F-Score3
WACC4.36%
ROIC/WACC0.61
Cap/Depr(3y)38.37%
Cap/Depr(5y)42.77%
Cap/Sales(3y)3.25%
Cap/Sales(5y)3.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.7%
Revenue growth 3Y6.82%
Revenue growth 5Y6.95%
Sales Q2Q%98.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51.13%
EBIT growth 3Y38.66%
EBIT growth 5Y31.31%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.7%
FCF growth 3Y99.96%
FCF growth 5Y-0.36%
OCF growth 1Y18.22%
OCF growth 3Y38.26%
OCF growth 5Y-1%